A pilot study of the efficacy and tolerability of bupropion extended release (Wellbutrin XL) for the treatment of major depressive disorder in women with breast cancer
Phase of Trial: Phase II/III
Latest Information Update: 24 Jul 2007
At a glance
- Drugs Bupropion (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 24 Jul 2007 The expected completion date for this trial is now 1 Jan 2007.
- 16 Nov 2005 New trial record.